Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)
China flag China · Delayed Price · Currency is CNY
32.20
+0.72 (2.29%)
At close: Feb 6, 2026

SHE:002422 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
6,3273,9744,6754,7292,9202,772
Short-Term Investments
-555.65579.39---
Trading Asset Securities
1,5091,9211,691448.11359.53265.42
Cash & Short-Term Investments
7,8356,4516,9465,1773,2793,037
Cash Growth
10.61%-7.13%34.17%57.88%7.96%34.79%
Accounts Receivable
5,8346,0986,1207,1986,4637,432
Other Receivables
109.38126.17162.49256.3221.92117.57
Receivables
5,9446,2246,2837,4546,6857,549
Inventory
3,4633,8013,8403,2143,3633,468
Other Current Assets
3,2631,4601,222804.22681.4645.3
Total Current Assets
20,50517,93618,29016,64914,00914,700
Property, Plant & Equipment
12,94713,01212,08611,33111,61411,987
Long-Term Investments
4,5834,2813,9923,8093,4092,751
Goodwill
98.6698.6698.6698.6698.66158.45
Other Intangible Assets
1,2071,2231,2771,2011,063987.8
Long-Term Deferred Tax Assets
419.49423.03342.57618.21581.57552.18
Long-Term Deferred Charges
63.9383.0675.72233.81365.28516.12
Other Long-Term Assets
280.27260.11293.17264.34400.05330.62
Total Assets
40,10437,31636,45534,20631,54031,983
Accounts Payable
2,2822,5742,5392,2442,1561,861
Accrued Expenses
479.22,2592,0281,9731,6102,525
Short-Term Debt
2,9402,4573,4584,4995,1835,067
Current Portion of Long-Term Debt
453.77808.4746.862,0123,1992,208
Current Portion of Leases
-62.5640.5317.3111.57-
Current Income Taxes Payable
259.75140.11162.74108.18119.4892.6
Current Unearned Revenue
392.42645.45839.83360.36264.69187.88
Other Current Liabilities
3,351190.71177.87889.3864.55316.52
Total Current Liabilities
10,1589,1389,99312,10413,40812,258
Long-Term Debt
193.553422,6494,7043,5065,100
Long-Term Leases
534.12537.46245.2351.7416.18-
Long-Term Unearned Revenue
318.78294.65288.21208.88225.73362.07
Long-Term Deferred Tax Liabilities
274.39266.09264.1265.83254.32260.55
Other Long-Term Liabilities
2.82-0.08---
Total Liabilities
11,48110,57813,43917,33517,41017,980
Common Stock
1,5981,6011,4991,4221,4251,439
Additional Paid-In Capital
8,7427,7326,1443,6733,5813,889
Retained Earnings
13,42213,22211,97310,4169,3288,675
Treasury Stock
-131.7-191.83-215.14-237.08-399.98-499.88
Comprehensive Income & Other
77.22115.84272.07459.82-77.49-3.51
Total Common Equity
23,70822,48019,67215,73413,85713,499
Minority Interest
4,9154,2593,3431,137272.62503.99
Shareholders' Equity
28,62326,73823,01616,87114,12914,003
Total Liabilities & Equity
40,10437,31636,45534,20631,54031,983
Total Debt
4,1214,2077,13911,28511,91612,375
Net Cash (Debt)
3,7152,243-193.52-6,108-8,637-9,337
Net Cash Per Share
2.321.42-0.13-4.12-6.11-6.53
Filing Date Shares Outstanding
1,6261,5911,4881,4121,4061,430
Total Common Shares Outstanding
1,6261,5911,4881,4121,4061,430
Working Capital
10,3478,7988,2974,545600.442,442
Book Value Per Share
14.5814.1313.2211.159.859.44
Tangible Book Value
22,40221,15818,29714,43412,69512,353
Tangible Book Value Per Share
13.7813.3012.2910.239.038.64
Buildings
-7,4646,5576,1606,0575,932
Machinery
-13,10111,59211,34811,07810,793
Construction In Progress
-1,2042,0451,126922.73840.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.